TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Scandbio AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
82,967
|
100,050
|
55,666 |
| Financial expenses |
311
|
4
|
20 |
| Earnings before taxes |
3,019
|
17,770
|
12,501 |
| EBITDA |
5,067
|
18,909
|
13,550 |
| Total assets |
54,566
|
54,105
|
56,066 |
| Current assets |
39,673
|
37,751
|
40,548 |
| Current liabilities |
19,407
|
26,461
|
18,073 |
| Equity capital |
27,913
|
26,461
|
36,914 |
| - share capital |
522
|
541
|
539 |
| Employees (average) |
104
|
103
|
106 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
51.2%
|
48.9%
|
65.8% |
| Turnover per employee |
798
|
971
|
525 |
| Profit as a percentage of turnover |
3.6%
|
17.8%
|
22.5% |
| Return on assets (ROA) |
6.1%
|
32.9%
|
22.3% |
| Current ratio |
204.4%
|
142.7%
|
224.4% |
| Return on equity (ROE) |
10.8%
|
67.2%
|
33.9% |
| Change turnover |
-13,682
|
44,222
|
-27,256 |
| Change turnover % |
-14%
|
79% | |
| Chg. No. of employees |
1
|
-3
|
-24 |
| Chg. No. of employees % |
1%
|
-3% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.